Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…

Dr. Shadman presents a case of a 68-year-old woman with symptomatic CLL requiring treatment. She has unmutated IGHV…

In an Around the Practice program hosted by CancerNetwork®, a panel of experts in thoracic oncology convened to…

Sonesitatug vedotin (Sone-Ve), an antibody-drug conjugate (ADC) targeting Claudin 18.2 (CLDN18.2), significantly improved overall survival (OS) in patients…

Real-world data from the AML Real-World EvidenCe (ARC) initiative showed that frequent venetoclax (Venclexta) dose modifications and drug…

Chimeric antigen receptor (CAR) T-cell therapy has moved from a later-line rescue option to a guideline-preferred second-line strategy…